FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Randolph Edward David 		2. Issuer Name and Ticker or Trading Symbol

SECOND SIGHT MEDICAL PRODUCTS INC [ EYES ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
Vice President of Manufacturin
(Last)          (First)          (Middle)

12744 SAN FERNANDO ROAD, SUITE 400 		3. Date of Earliest Transaction (MM/DD/YYYY)

12/1/2017
(Street)

SYLMAR, CA 91342
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   11/30/2017   11/30/2017   A    18553   (1) A $0.96   18575   D    
Common Stock   12/1/2017   12/1/2017   A    18553   D $1.25   22   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Non-Qualified Stock Option (right to buy)   $1.9700                    1/3/2018   (2) 1/3/2027   Common Stock   151170     151170   D    
Non-Qualified Stock Option (right to buy)   $4.1000                    1/21/2017   (2) 1/21/2026   Common Stock   11513     11513   D    
Non-Qualified Stock Option (right to buy)   $5.0000                    2/1/2009   (3) 2/1/2018   Common Stock   2290     2290   D    
Non-Qualified Stock Option (right to buy)   $5.0000                    11/1/2009   (3) 11/1/2018   Common Stock   25000     25000   D    
Non-Qualified Stock Option (right to buy)   $5.0000                    2/1/2010   (3) 2/1/2019   Common Stock   6750     6750   D    
Non-Qualified Stock Option (right to buy)   $5.0000                    2/1/2011   (3) 2/1/2020   Common Stock   20750     20750   D    
Non-Qualified Stock Option (right to buy)   $5.0000                    3/1/2012   (3) 3/1/2021   Common Stock   8313     8313   D    
Non-Qualified Stock Option (right to buy)   $5.0000                    3/1/2013   (3) 3/1/2022   Common Stock   7750     7750   D    
Non-Qualified Stock Option (right to buy)   $5.0000                    4/1/2015   (3) 4/1/2024   Common Stock   10937     10937   D    
Non-Qualified Stock Option (right to buy)   $9.0000                    9/26/2015   (3) 9/26/2024   Common Stock   65895     65895   D    
Non-Qualified Stock Option (right to buy)   $13.0900                    3/25/2016   (3) 3/25/2025   Common Stock   6250     6250   D    

Explanation of Responses:
(1)  18,553 shares, acquired as part of scheduled ESSP purchases on 11/30/2017 and sold on 12/1/2017.
(2)  Options vest over a four year term of which one-fourth vests on the Date Exercisable, with the remaining options vesting quarterly over three years thereafter.
(3)  Options vest in 4 yearly increments starting with the Date Exercisable.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Randolph Edward David
12744 SAN FERNANDO ROAD
SUITE 400
SYLMAR, CA 91342

Vice President of Manufacturin

Signatures
/s/ Edward Randolph 12/4/2017
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Second Sight Medical Pro... (NASDAQ:EYES)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Second Sight Medical Pro... Charts.
Second Sight Medical Pro... (NASDAQ:EYES)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Second Sight Medical Pro... Charts.